USFDA classifies inspection of Cadila's Moraiya facility as OAI

Cadila Healthcare has received a letter from USFDA classifying the inspection conducted at the company's Moraiya facility located at Ahmedabad, Gujarat from 22 April - 03 May 2019 as 'Official Action Indicated'.

The Company believes that this classification will not have any impact on the current supplies or revenues of this facility.

The Company is in the process of sending further updates of its corrective actions to the U.S. FDA and remains hopeful of a positive outcome.

Powered by Capital Market - Live News